[250 Pages Report] The tissue sealants and tissue adhesive market is anticipated to register a CAGR of 8.4% during the forecast period, up from US$ 1,509.6 Million in 2021 to reach a valuation of US$ 2,876.9 Million by 2027.
| Report Attributes | Details |
|---|---|
| Estimated Base Year Value (2021) | US$ 1,509.8 Million |
| Anticipated Forecast Value (2027) | US$ 2,876.9 Million |
| Projected Growth Rate (2022 to 2032) | 8.4% CAGR |
Sales of tissue sealants and tissue adhesives are expected to decline as key companies in the market are employing them to rebuild peripheral nerves.
In addition to this, demand for tissue sealants and tissue adhesive is rising because bone-related disorders are expected to propel the growth of the global tissue glue and bio-adhesive sealants market over the forecast period.
For instance, according to the paper 'New Osteoporotic/Vertebral Compression Fractures', published in 2018 by National Center for Biotechnology Information (NCBI), the U.S. records 700,000 cases of vertebral compression fractures annually.
Increasing R&D in tissue glue and bio-adhesive sealants is also projected to contribute to the growth of the tissue sealants and tissue adhesive market share.
The report sheds light on the factors improving the sales of tissue sealants and tissue adhesive and, in turn, the opportunities for the market players. However, the tissue sealants and tissue adhesive market also face some challenges, which might limit the tissue sealants and tissue adhesive market share from reaching its potential.
Some of the key tissue sealants and tissue adhesive market trends promoting the demand for tissue sealants and tissue adhesive include being employed by key companies to rebuild peripheral nerves.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The tissue sealing and tissue adhesive market are driven by increasing sales of tissue sealants and tissue adhesive products among surgeons due to their efficacy in preventing bleeding during surgery.
These tissue sealants diminish post-operative bleeding. In addition, these tissue sealants are highly effective, easy to use and less prone to microbial infection after surgery.
Factors such as aging the population and rising surgical procedures result in the increased demand for Tissue sealing and tissue adhesive globally.
The stringent regulatory policies and high cost of the products are major restraints of the sales of tissue sealants and tissue adhesive.
The global tissue sealants and tissue adhesive market is predicted to profit from the rising demand for tissue sealants and tissue adhesive number of operations and amputations.
The growth in the number of arthroplasty surgeries is also likely to help expand the sales of tissue sealants and tissue adhesive.
Depending upon the geographic regions global tissue sealants and adhesives market is segmented into seven key regions-North America, Latin America, Eastern Europe, Western Europe, and the Asia Pacific, excluding Japan, Japan, Middle East and Africa.
North America dominates global sales of tissue sealants and tissue adhesive due to the significant spending power of the population and technological advancement. However, Asia Pacific countries are anticipated to witness lucrative growth in demand for tissue sealants and the tissue adhesive market.
Increasing demand for tissue sealants and tissue adhesive market will be driven by increased investments in healthcare infrastructure and state-of-the-art medical research facilities in the Middle East and Africa during the forecast period, as well as a growing population, improved life expectancy, and increased awareness among both patients and physicians regarding available treatment options.
Government-driven price management and reimbursement limits are becoming more common in the APAC region, notably in China and Japan. At the same time, the South American sector remains undeveloped due to a lack of knowledge and price sensitivity in the sales of tissue sealants and adhesives.
Principal Consultant
The key players in the global tissue sealants and tissue adhesive market are Baxter International Inc., Johnson & Johnson, Exapharma, Smith & Nephew, C.R Bard and Integra LifeSciences.
The sales of tissue sealants and tissue adhesive is led by Johnson & Johnson (Ethicon, Inc.) (US). The corporation has a well-known brand and a significant regional presence.
It has a robust and diverse product range for surgical sealants and adhesives, including some of the most well-known names.
The report consists of key players contributing to tissue sealants and tissue adhesive market share. It also consists of organic and inorganic growth strategies adopted by market players to improve their market positions. This exclusive report analyses the competitive landscape and the market share of tissue sealants and tissue adhesive by players to strengthen their market position.
Key participants in the sales of tissue sealants and tissue adhesive are focusing on product development and approval to grow their product range. Polygamic, for example, acquired CE certification for LIQOSEAL, an easy-to-use and novel dural sealant patch, in January 2020.
Sales of tissue and tissue Adhesu Market participants are increasingly adopting inorganic operations. CryoLife, Inc., for example, teamed with Misonix in December 2019 to commercialize CryoLife's NeoPatch product for the treatment of a variety of diseases outside of cardiac and vascular surgery.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Report Attributes | Details |
|---|---|
| Growth Rate | CAGR of 8.4% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2020 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in US$ Billion, Volume in Kilotons and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Product Type, Application, End user Region, |
| Regions Covered | North America; Latin America; Western Europe; Eastern Europe; Asia Pacific; Japan; Middle East and Africa |
| Key Countries Profiled | USA; Canada; Mexico; Brazil; Germany; Italy; UK; Spain; France; Russia; China; India; ASEAN; Australia & New Zealand; Japan; GCG; South Africa |
| Key Companies Profiled | Baxter International Inc.; Johnson & Johnson; Exapharma; Smith & Nephew; C.R Bard and Integra LifeSciences |
| Customization Scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
The tissue sealants and tissue adhesive market is anticipated to register a CAGR of 8.4% during the forecast period.
Key players holding substantial market share include Baxter International Inc., Johnson & Johnson, Exapharma, Smith & Nephew, C.R Bard, and Integra Life Sciences.
As per the analysis, the tissues sealants and tissue adhesive market share is likely to be US$ 2876.9 Mn by 2027.
Demand for tissue sealants and tissue adhesive is likely to rise on the back of sales of tissue sealants and tissue adhesive products among surgeons due to its efficacy to prevent bleeding during surgery.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Tissue Sealants and Tissue Adhesive Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Bn) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Bn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Tissue Sealants and Tissue Adhesive Market Analysis 2017-2021 and Forecast 2022-2032, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Bn) Analysis By Product, 2017-2021 5.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Product, 2022-2032 5.3.1. Tissue Adhesives 5.3.2. Tissue Sealants 5.4. Y-o-Y Growth Trend Analysis By Product, 2017-2021 5.5. Absolute $ Opportunity Analysis By Product, 2022-2032 Deep-dive segmentation will be available in the sample on request 6. Global Tissue Sealants and Tissue Adhesive Market Analysis 2017-2021 and Forecast 2022-2032, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Bn) Analysis By Application, 2017-2021 6.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Application, 2022-2032 6.3.1. Surgical Procedures 6.3.2. Trauma Cases 6.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021 6.5. Absolute $ Opportunity Analysis By Application, 2022-2032 Deep-dive segmentation will be available in the sample on request 7. Global Tissue Sealants and Tissue Adhesive Market Analysis 2017-2021 and Forecast 2022-2032, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Bn) Analysis By End User, 2017-2021 7.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By End User, 2022-2032 7.3.1. Hospitals 7.3.2. Ambulatory Surgical Centers 7.3.3. Clinics 7.3.4. Emergence Medical Services 7.3.5. Long Term Care Centers 7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021 7.5. Absolute $ Opportunity Analysis By End User, 2022-2032 Deep-dive segmentation will be available in the sample on request 8. Global Tissue Sealants and Tissue Adhesive Market Analysis 2017-2021 and Forecast 2022-2032, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Bn) Analysis By Region, 2017-2021 8.3. Current Market Size Value (US$ Bn) Analysis and Forecast By Region, 2022-2032 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. East Asia 8.3.5. South Asia & Pacific 8.3.6. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Tissue Sealants and Tissue Adhesive Market Analysis 2017-2021 and Forecast 2022-2032, By Country 9.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021 9.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032 9.2.1. By Country 9.2.1.1. U.K. 9.2.1.2. Canada 9.2.2. By Product 9.2.3. By Application 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product 9.3.3. By Application 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Tissue Sealants and Tissue Adhesive Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product 10.2.3. By Application 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By Application 10.3.4. By End User 10.4. Key Takeaways 11. Europe Tissue Sealants and Tissue Adhesive Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. U.K. 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Product 11.2.3. By Application 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By Application 11.3.4. By End User 11.4. Key Takeaways 12. East Asia Tissue Sealants and Tissue Adhesive Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.2. By Product 12.2.3. By Application 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By Application 12.3.4. By End User 12.4. Key Takeaways 13. South Asia & Pacific Tissue Sealants and Tissue Adhesive Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Thailand 13.2.1.3. Indonesia 13.2.1.4. Malaysia 13.2.1.5. Singapore 13.2.1.6. Australia 13.2.1.7. New Zealand 13.2.1.8. Rest of South Asia & Pacific 13.2.2. By Product 13.2.3. By Application 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By Application 13.3.4. By End User 13.4. Key Takeaways 14. MEA Tissue Sealants and Tissue Adhesive Market Analysis 2017-2021 and Forecast 2022-2032, By Country 14.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021 14.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Product 14.2.3. By Application 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product 14.3.3. By Application 14.3.4. By End User 14.4. Key Takeaways 15. Key Countries Tissue Sealants and Tissue Adhesive Market Analysis 15.1. U.K. 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2021 15.1.2.1. By Product 15.1.2.2. By Application 15.1.2.3. By End User 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2021 15.2.2.1. By Product 15.2.2.2. By Application 15.2.2.3. By End User 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2021 15.3.2.1. By Product 15.3.2.2. By Application 15.3.2.3. By End User 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2021 15.4.2.1. By Product 15.4.2.2. By Application 15.4.2.3. By End User 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2021 15.5.2.1. By Product 15.5.2.2. By Application 15.5.2.3. By End User 15.6. U.K. 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2021 15.6.2.1. By Product 15.6.2.2. By Application 15.6.2.3. By End User 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2021 15.7.2.1. By Product 15.7.2.2. By Application 15.7.2.3. By End User 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2021 15.8.2.1. By Product 15.8.2.2. By Application 15.8.2.3. By End User 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2021 15.9.2.1. By Product 15.9.2.2. By Application 15.9.2.3. By End User 15.10. China 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2021 15.10.2.1. By Product 15.10.2.2. By Application 15.10.2.3. By End User 15.11. Japan 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2021 15.11.2.1. By Product 15.11.2.2. By Application 15.11.2.3. By End User 15.12. South Korea 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2021 15.12.2.1. By Product 15.12.2.2. By Application 15.12.2.3. By End User 15.13. India 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2021 15.13.2.1. By Product 15.13.2.2. By Application 15.13.2.3. By End User 15.14. Thailand 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2021 15.14.2.1. By Product 15.14.2.2. By Application 15.14.2.3. By End User 15.15. Indonesia 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2021 15.15.2.1. By Product 15.15.2.2. By Application 15.15.2.3. By End User 15.16. Malaysia 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2021 15.16.2.1. By Product 15.16.2.2. By Application 15.16.2.3. By End User 15.17. Singapore 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2021 15.17.2.1. By Product 15.17.2.2. By Application 15.17.2.3. By End User 15.18. Australia 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2021 15.18.2.1. By Product 15.18.2.2. By Application 15.18.2.3. By End User 15.19. New Zealand 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2021 15.19.2.1. By Product 15.19.2.2. By Application 15.19.2.3. By End User 15.20. GCC Countries 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2021 15.20.2.1. By Product 15.20.2.2. By Application 15.20.2.3. By End User 15.21. South Africa 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2021 15.21.2.1. By Product 15.21.2.2. By Application 15.21.2.3. By End User 15.22. Israel 15.22.1. Pricing Analysis 15.22.2. Market Share Analysis, 2021 15.22.2.1. By Product 15.22.2.2. By Application 15.22.2.3. By End User 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Product 16.3.3. By Application 16.3.4. By End User 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Smith & Nephew 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.2. Baxter International, Inc. 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.3. Ethicon US, LLC. 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.4. B. Braun Medical, Inc. 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.5. C.R Bard, Inc. 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.6. Cryo Life 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.7. Medtronic 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.8. Advanced Medical Solutions Group plc. 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.9. Equimedical 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.10. CSL Behring 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Tissue Sealants and Tissue Adhesive Market
